| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:ITI-333
CAS:2117619-00-6
Package:10mg;50mg
|
|
| | ITI-333 Basic information |
| Product Name: | ITI-333 | | Synonyms: | ITI-333;1H-Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-2(3H)-one, 8-[3-(4-fluorophenoxy)propyl]-6b,7,8,9,10,10a-hexahydro-, (6bR,10aS)- | | CAS: | 2117619-00-6 | | MF: | C22H24FN3O2 | | MW: | 381.44 | | EINECS: | | | Product Categories: | | | Mol File: | 2117619-00-6.mol |  |
| | ITI-333 Chemical Properties |
| Boiling point | 573.725±50.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.337±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 14.083±0.20(predicted) |
| | ITI-333 Usage And Synthesis |
| Uses | ITI-333 is a tetracyclic compound with oral bioavailability and analgesic activity, targeting multiple receptors. ITI-333 can be used for research on various forms of pain[1]. | | References | [1] Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders
[2] Li P, et al. Discovery of ITI-333, a Novel Orally Bioavailable Molecule Targeting Multiple Receptors for the Treatment of Pain and Other Disorders[J]. Journal of Medicinal Chemistry, 2024. DOI:10.1021/acs.jmedchem.4c00480 |
| | ITI-333 Preparation Products And Raw materials |
|